Pharma-services

Transforming Care, Delivering Excellence

Advancing Healthcare Through Pharmacy Innovation and Expertise

India is the largest provider of generic drugs globally and is known for its affordable vaccines and generic medications. The Indian Pharmaceutical industry is currently ranked third in pharmaceutical production by volume after evolving over time into a thriving industry growing at a CAGR of 9.43% since the past nine years. Generic drugs, over-the-counter medications, bulk drugs, vaccines, contract research & manufacturing, biosimilars, and biologics are some of the major segments of the Indian pharma industry. India has highest number of pharmaceutical manufacturing facilities that comply with the US Food and Drug Administration (USFDA) and has 500 API producers that make for around 8% of the worldwide API market.

Empowering healthcare professionals with specialized pharmacy skills and knowledge to excel in patient care and pharmaceutical advancements across diverse domains

Advancing Healthcare Through Pharmacy Expertise

Diversified Specialty and Generics Portfolio

We manufacture and market a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates. Our broad portfolio of more than 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids.

Every year, we sell over 30 billion doses covering neuro-psychiatry, cardiology, gastroenterology, anti-infectives, diabetology, oncology, ophthalmology, dermatology, urology, nephrology and respiratory among others.

Driven by Innovation

The first among Indian pharmaceutical companies to realise and embrace the importance of investing in research, we invest up to 6-8% of our global revenues into Research and Development (R&D) every year.

Our core strength lies in our ability to excel in developing generics and technologically complex products backed by our dedicated teams in formulations, process chemistry, and analytical development.

Our capabilities extend beyond the development of differentiated products, including liposomal products, inhalers, lyophilized injections, nasal sprays, and controlled release dosage forms.

Our R&D team comprises over 2,800 people.

Global Footprint

From humble beginnings in 1983, Crestvision Pharma has grown to become one of the largest generic pharmaceutical companies worldwide. We are the largest pharmaceutical company in India.

In the US, we are among the leading generic pharmaceutical companies and are ranked second by prescriptions in the generic dermatology market.

We are the largest Indian company in emerging markets with a presence in over 80 markets. Brazil, Mexico, Russia, Romania and South Africa are some of our key emerging markets.

We are present across all major markets in Western Europe, Canada, Australia, New Zealand, Japan and China among others.

Our presence in emerging markets and the developing world enables our teams to cross-sell and build brands with ease.

Best Services

Products

We produce a comprehensive, diverse and highly complementary portfolio of medicines targeting a wide spectrum of chronic and acute treatments. Our product portfolio includes generics, branded generics, speciality, difficult-to-make technology intensive products, over-the-counter (OTC), anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates. Our presence in more than 100 countries helps us in being responsive to local treatment needs while continually improving our global product offering.

Speciality Medications

Crestvision Pharma has built a portfolio of patent protected speciality medicines for global markets. Over the years, we have nurtured this evolving business through increased focus and investments. The key segments we are targeting are dermatology, ophthalmology and oncology. Our focus is on improving patient outcomes either by addressing unmet medical needs or by enhancing patient convenience through differentiated dosage forms. Our initiatives in this segment cover the entire value chain, from in-licensing early-to-late stage clinical candidates, as well as getting access to on-market patented products. Today, we are among the leading branded companies in the US with several speciality products launched in the country.

Generic Medications

We provide high quality generic and branded medicines at affordable costs to patients and doctors in more than 100 countries worldwide. Our products have the hallmark of technology-based differentiation and cover the full range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams and liquids. The therapeutic segments covered by our portfolio of over 2000 molecules include psychiatry, anti-infectives, neurology, cardiology, orthopaedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. In several countries, Sun Pharma ranks among the leading companies in these therapy areas.

Tech Set Ups

We provide a range of over-the-counter (OTC) / consumer healthcare products. Faringosept (sore throat), Revital (vitamins) and Volini (topical analgesics) are a few of our flagship OTC brands that are marketed in several countries globally. There are other category defining brands such as Coldact & Flustat (cold & flu), Brustan, Painamol & Paduden (analgesics), Aspenter, Aspacardin, Nudrate & Fortifikat (lifestyle OTCs), Gestid (digestives) and Chericof (cough).

Start WhatsApp chat

Scan the code

Hello 👋
Can we help you?